Related Experiment Video
Updated: Jun 20, 2026
Systemic Bacterial Infection and Immune Defense Phenotypes in Drosophila Melanogaster
Published on: May 13, 2015
Drosomycin, an essential component of antifungal defence in Drosophila
1Group of Animal Innate Immunity, State Key Laboratory of Integrated Management of Pest Insects & Rodents, Institute of Zoology, Chinese Academy of Sciences, Beijing, China.
Abstract:
Drosomycin is an inducible antifungal peptide of 44 residues initially isolated from bacteria-challenged Drosophila melanogaster. The systemic expression of drosomycin is regulated by the Toll pathway present in fat body, whereas inducible local expression in the respiratory tract is controlled by the Immune Deficiency (IMD) pathway. Drosomycin belongs to the cysteine-stabilized alpha-helical and beta-sheet (CSalphabeta) superfamily and is composed of an alpha-helix and a three-stranded beta-sheet stabilized by four disulphide bridges. Drosomycin exhibits a narrow antimicrobial spectrum and is only active against some filamentous fungi. However, recent work using recombinant drosomycin expressed in Escherichia coli revealed its antiparasitic and anti-yeast activities. Two evolutionary epitopes (alpha- and gamma-patch) and the m-loop have been proposed as putative functional regions of drosomycin for interaction with fungi and parasites, respectively. Similarity in sequence, structure and biological activity suggests that drosomycin and some defensin molecules from plants and fungi could originate from a common ancestor.
Insights
Drosomycin, an antifungal peptide from fruit flies, shows new antiparasitic and anti-yeast activities. This discovery expands its potential applications beyond fungi, highlighting its evolutionary links to defensins.
Area of Science:
- Molecular Biology
- Immunology
- Evolutionary Biology
Background:
- Drosomycin is an inducible antifungal peptide from Drosophila melanogaster.
- Its expression is regulated by the Toll and Immune Deficiency (IMD) pathways.
- Drosomycin is a member of the cysteine-stabilized alpha-helical and beta-sheet (CSalphabeta) superfamily.
Purpose of the Study:
- To investigate the broader antimicrobial spectrum of drosomycin.
- To identify potential functional regions involved in drosomycin's interactions.
- To explore the evolutionary origins of drosomycin.
Main Methods:
- Expression of recombinant drosomycin in Escherichia coli.
- Antimicrobial assays against various pathogens.
- Sequence and structural analysis.
Main Results:
- Recombinant drosomycin demonstrated antiparasitic and anti-yeast activities, expanding its known spectrum.
- The alpha-patch, gamma-patch, and m-loop were proposed as key functional regions.
- Drosomycin shares similarities with plant and fungal defensins, suggesting a common ancestor.
Conclusions:
- Drosomycin possesses a broader biological activity profile than previously known.
- Specific regions of drosomycin are crucial for its interactions with different targets.
- Drosomycin and defensins likely evolved from a common ancestral molecule.
